Pharmaron has joined the National Chemical Biological Alliance centered in the Frederick National Laboratory. The company will actively participate in the development of treatments in the fight against cancer.

The Frederick National Laboratory is sponsored by the National Cancer Institute. Its world-class expertise is applied to high throughput screening, structural biology, medicinal chemistry, anticancer medicine, comprehensive analysis of tumor cell biology and animal models of research and development. Pharmaron is the 22nd member of the alliance, and specifically targets drug metabolism and bioanalytical research services.